{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:04:20Z","timestamp":1789434260196,"version":"build-2803163510"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The pathogenesis of Parkinson\u2019s disease (PD) remains incompletely understood, and effective early diagnostic biomarkers and disease-modifying therapies are lacking. MicroRNAs (miRNAs), a class of small non-coding RNAs, have emerged as critical regulators of gene expression involved in key pathological processes of PD, including neuronal apoptosis, mitochondrial dysfunction, oxidative stress, and \u03b1-synuclein (\u03b1-syn) aggregation. Recent evidence suggests that dysregulated miRNAs expression contributes significantly to PD progression and may serve as minimally invasive biomarkers for early diagnosis. Furthermore, miRNA-based therapeutic strategies offer promising avenues for targeting disease-related molecular pathways. This review summarizes the mechanistic roles of miRNAs in PD pathogenesis and highlights their potential clinical applications in diagnosis and therapy.<\/jats:p>","DOI":"10.1007\/s10571-026-01767-x","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:08:31Z","timestamp":1782454111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Diagnostic and Therapeutic Value of Micro-RNA in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Guo-Liang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Huan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1767_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00228","volume":"9","author":"L Accomasso","year":"2018","unstructured":"Accomasso L, Cristallini C, Giachino C (2018) Risk assessment and risk minimization in nanomedicine: a need for predictive, alternative, and 3Rs strategies. Front Pharmacol 9:228. https:\/\/doi.org\/10.3389\/fphar.2018.00228","journal-title":"Front Pharmacol"},{"key":"1767_CR2","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.phrs.2019.104515","volume":"150","author":"E Angelopoulou","year":"2019","unstructured":"Angelopoulou E, Paudel YN, Piperi C (2019) miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacol Res 150:104515. https:\/\/doi.org\/10.1016\/j.phrs.2019.104515","journal-title":"Pharmacol Res"},{"issue":"2","key":"1767_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/TP.0b013e3181e913c2","volume":"27","author":"D Anglicheau","year":"2010","unstructured":"Anglicheau D, Muthukumar T, Suthanthiran M (2010) MicroRNAs: small RNAs with big effects. Transplantation 27(2):105\u2013112. https:\/\/doi.org\/10.1097\/TP.0b013e3181e913c2","journal-title":"Transplantation"},{"issue":"6","key":"1767_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"11","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 11(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"1","key":"1767_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12031-009-9325-1","volume":"41","author":"S Asikainen","year":"2010","unstructured":"Asikainen S, Rudgalvyte M, Heikkinen L et al (2010) Global microRNA expression profiling of Caenorhabditis elegans Parkinson\u2019s disease models. J Mol Neurosci 41(1):210\u2013218. https:\/\/doi.org\/10.1007\/s12031-009-9325-1","journal-title":"J Mol Neurosci"},{"issue":"23\u201324","key":"1767_CR6","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/elps.201800526","volume":"40","author":"S Ayala-Mar","year":"2019","unstructured":"Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, Perez-Gonzalez VH, Gonzalez-Valdez J (2019) Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis 40(23\u201324):3036\u20133049. https:\/\/doi.org\/10.1002\/elps.201800526","journal-title":"Electrophoresis"},{"issue":"5","key":"1767_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00415-020-10291-x","volume":"268","author":"J Baskin","year":"2021","unstructured":"Baskin J, Jeon JE, Lewis SJG (2021) Nanoparticles for drug delivery in Parkinson\u2019s disease. J Neurol 268(5):1981\u20131994. https:\/\/doi.org\/10.1007\/s00415-020-10291-x","journal-title":"J Neurol"},{"key":"1767_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuint.2016.10.001","volume":"101","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Borah A (2016) Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson\u2019s disease. Neurochem Int 101:48\u201355. https:\/\/doi.org\/10.1016\/j.neuint.2016.10.001","journal-title":"Neurochem Int"},{"issue":"2","key":"1767_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 19(2):170\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"Lancet Neurol"},{"issue":"10291","key":"1767_CR10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"2","key":"1767_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21(2):85\u2013100. https:\/\/doi.org\/10.1038\/s41580-019-0173-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1767_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137229","author":"L Bodai","year":"2024","unstructured":"Bodai L, Borosta R, Ferencz A, Kovacs M, Zsindely N (2024) The role of miR-137 in neurodegenerative disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137229","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1767_CR13","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"1","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Di Lazzaro G, Marino G, Campanelli F, Ghiglieri V (2023) Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease. Brain 1(9):3587\u20133597. https:\/\/doi.org\/10.1093\/brain\/awad150","journal-title":"Brain"},{"issue":"1","key":"1767_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.692","volume":"12","author":"L Caldi Gomes","year":"2022","unstructured":"Caldi Gomes L, Galhoz A, Jain G et al (2022) Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson\u2019s disease. Clin Transl Med 12(1):e692. https:\/\/doi.org\/10.1002\/ctm2.692","journal-title":"Clin Transl Med"},{"key":"1767_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"XY Cao","year":"2017","unstructured":"Cao XY, Lu JM, Zhao ZQ et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399. https:\/\/doi.org\/10.1016\/j.neulet.2017.02.045","journal-title":"Neurosci Lett"},{"issue":"4","key":"1767_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s12031-014-0428-y","volume":"54","author":"LF Cardo","year":"2014","unstructured":"Cardo LF, Coto E, Ribacoba R et al (2014) MiRNA profile in the substantia nigra of Parkinson\u2019s disease and healthy subjects. J Mol Neurosci 54(4):830\u2013836. https:\/\/doi.org\/10.1007\/s12031-014-0428-y","journal-title":"J Mol Neurosci"},{"key":"1767_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050865","author":"LA Citterio","year":"2023","unstructured":"Citterio LA, Mancuso R, Agostini S, Meloni M, Clerici M (2023) Serum and exosomal miR-7-1-5p and miR-223-3p as possible biomarkers for Parkinson\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom13050865","journal-title":"Biomolecules"},{"issue":"3","key":"1767_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.molmed.2018.01.006","volume":"24","author":"IL Colao","year":"2018","unstructured":"Colao IL, Corteling R, Bracewell D, Wall I (2018) Manufacturing exosomes: a promising therapeutic platform. Trends Mol Med 24(3):242\u2013256. https:\/\/doi.org\/10.1016\/j.molmed.2018.01.006","journal-title":"Trends Mol Med"},{"issue":"3","key":"1767_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mds.27935","volume":"35","author":"M Cressatti","year":"2020","unstructured":"Cressatti M, Juwara L, Galindez JM et al (2020) Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson\u2019s Disease. Mov Disord 35(3):468\u2013477. https:\/\/doi.org\/10.1002\/mds.27935","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"1767_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41434-020-00197-8","volume":"29","author":"MR Cring","year":"2022","unstructured":"Cring MR, Sheffield VC (2022) Gene therapy and gene correction: targets, progress, and challenges for treating human diseases. Gene Ther 29(1\u20132):3\u201312. https:\/\/doi.org\/10.1038\/s41434-020-00197-8","journal-title":"Gene Ther"},{"issue":"6","key":"1767_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s Disease. Neuron 39(6):889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"issue":"12","key":"1767_CR22","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.4103\/NRR.NRR-D-23-01677","volume":"1","author":"MI De Bartolo","year":"2024","unstructured":"De Bartolo MI, Belvisi D, Mancinelli R et al (2024) A systematic review of salivary biomarkers in Parkinson\u2019s disease. Neural Regen Res 1(12):2613\u20132625. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01677","journal-title":"Neural Regen Res"},{"issue":"8","key":"1767_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","volume":"14","author":"B Dehay","year":"2015","unstructured":"Dehay B, Bourdenx M, Gorry P et al (2015) Targeting alpha-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations. Lancet Neurol 14(8):855\u2013866. https:\/\/doi.org\/10.1016\/S1474-4422(15)00006-X","journal-title":"Lancet Neurol"},{"issue":"10","key":"1767_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd.2018.158","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY (2018) Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17(10):767. https:\/\/doi.org\/10.1038\/nrd.2018.158","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"1767_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY (2018) Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17(9):641\u2013659. https:\/\/doi.org\/10.1038\/nrd.2018.110","journal-title":"Nat Rev Drug Discov"},{"key":"1767_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010355","author":"A Di Rita","year":"2020","unstructured":"Di Rita A, Maiorino T, Bruqi K, Volpicelli F, Bellenchi GC, Strappazzon F (2020) miR-218 inhibits mitochondrial clearance by targeting PRKN E3 ubiquitin ligase. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21010355","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1767_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38(6):613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006","journal-title":"Trends Genet"},{"key":"1767_CR28","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dionisio","year":"2021","unstructured":"Dionisio PA, Amaral JD, Rodrigues CMP (2021) Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res Rev 67:101263. https:\/\/doi.org\/10.1016\/j.arr.2021.101263","journal-title":"Ageing Res Rev"},{"issue":"6","key":"1767_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong X (2018) Current strategies for brain drug delivery. Theranostics 8(6):1481\u20131493. https:\/\/doi.org\/10.7150\/thno.21254","journal-title":"Theranostics"},{"key":"1767_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094610","author":"J Doroszkiewicz","year":"2022","unstructured":"Doroszkiewicz J, Groblewska M, Mroczko B (2022) Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094610","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1767_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic-a call to action. JAMA Neurol 75(1):9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"issue":"17","key":"1767_CR32","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional Regulation of \u03b1-Synuclein Expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201334. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"issue":"4","key":"1767_CR33","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","volume":"1","author":"MA Eldeeb","year":"2022","unstructured":"Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA (2022) Mitochondrial quality control in health and in Parkinson\u2019s disease. Physiol Rev 1(4):1721\u20131755. https:\/\/doi.org\/10.1152\/physrev.00041.2021","journal-title":"Physiol Rev"},{"issue":"43","key":"1767_CR34","doi-asserted-by":"publisher","first-page":"e1907308","DOI":"10.1002\/smll.201907308","volume":"16","author":"D Eleftheriadou","year":"2020","unstructured":"Eleftheriadou D, Kesidou D, Moura F, Felli E, Song W (2020) Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases. Small 16(43):e1907308. https:\/\/doi.org\/10.1002\/smll.201907308","journal-title":"Small"},{"issue":"4","key":"1767_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS (2019) Emerging therapies in Parkinson disease - repurposed drugs and new approaches. Nat Rev Neurol 15(4):204\u2013223. https:\/\/doi.org\/10.1038\/s41582-019-0155-7","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1767_CR36","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s11064-024-04130-y","volume":"49","author":"M Esteves","year":"2024","unstructured":"Esteves M, Cristovao AC, Vale A, Machado-Pereira M, Ferreira R, Bernardino L (2024) MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson\u2019s Disease. Neurochem Res 49(7):1677\u20131686. https:\/\/doi.org\/10.1007\/s11064-024-04130-y","journal-title":"Neurochem Res"},{"issue":"1","key":"1767_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY et al (2020) Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflammation 17(1):11. https:\/\/doi.org\/10.1186\/s12974-019-1670-6","journal-title":"J Neuroinflammation"},{"issue":"5755","key":"1767_CR38","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1126\/science.1121158","volume":"16","author":"KK Farh","year":"2005","unstructured":"Farh KK, Grimson A, Jan C et al (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 16(5755):1817\u20131821. https:\/\/doi.org\/10.1126\/science.1121158","journal-title":"Science"},{"issue":"8","key":"1767_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.tcb.2015.03.003","volume":"25","author":"DA Flusberg","year":"2015","unstructured":"Flusberg DA, Sorger PK (2015) Surviving apoptosis: life-death signaling in single cells. Trends Cell Biol 25(8):446\u2013458. https:\/\/doi.org\/10.1016\/j.tcb.2015.03.003","journal-title":"Trends Cell Biol"},{"issue":"10423","key":"1767_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"20","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, Bruno V, Fox S, Kuhn AA, Lindop F, Lees AJ (2024) Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 20(10423):305\u2013324. https:\/\/doi.org\/10.1016\/S0140-6736(23)01429-0","journal-title":"Lancet"},{"issue":"2","key":"1767_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1152\/physrev.00011.2017","volume":"98","author":"M Fricker","year":"2018","unstructured":"Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC (2018) Neuronal cell death. Physiol Rev 98(2):813\u2013880. https:\/\/doi.org\/10.1152\/physrev.00011.2017","journal-title":"Physiol Rev"},{"issue":"1","key":"1767_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20(1):21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1767_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12951-019-0526-7","volume":"3","author":"C Gong","year":"2019","unstructured":"Gong C, Tian J, Wang Z et al (2019) Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnol 3(1):93. https:\/\/doi.org\/10.1186\/s12951-019-0526-7","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"1767_CR44","first-page":"1775","volume":"10","author":"A Gonzalez-Horta","year":"2015","unstructured":"Gonzalez-Horta A (2015) The Interaction of Alpha-synuclein with Membranes and its Implication in Parkinson\u2019s Disease: A Literature Review. Nat Prod Commun 10(10):1775\u20131778","journal-title":"Nat Prod Commun"},{"issue":"7886","key":"1767_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonzalez-Rodriguez","year":"2021","unstructured":"Gonzalez-Rodriguez P, Zampese E, Stout KA et al (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"issue":"1","key":"1767_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41593-019-0556-3","volume":"23","author":"SM Graves","year":"2020","unstructured":"Graves SM, Xie Z, Stout KA et al (2020) Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain. Nat Neurosci 23(1):15\u201320. https:\/\/doi.org\/10.1038\/s41593-019-0556-3","journal-title":"Nat Neurosci"},{"issue":"1","key":"1767_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","volume":"74","author":"H Grosso Jasutkar","year":"2022","unstructured":"Grosso Jasutkar H, Oh SE, Mouradian MM (2022) Therapeutics in the Pipeline Targeting alpha-Synuclein for Parkinson\u2019s Disease. Pharmacol Rev 74(1):207\u2013237. https:\/\/doi.org\/10.1124\/pharmrev.120.000133","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1767_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"QQ Han","year":"2023","unstructured":"Han QQ, Le WD (2023) NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson\u2019s Disease. Neurosci Bull 39(5):832\u2013844. https:\/\/doi.org\/10.1007\/s12264-023-01023-y","journal-title":"Neurosci Bull"},{"issue":"5","key":"1767_CR49","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","volume":"19","author":"R Han","year":"2023","unstructured":"Han R, Liu Y, Li S, Li XJ, Yang W (2023) PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. Autophagy 19(5):1396\u20131405. https:\/\/doi.org\/10.1080\/15548627.2022.2139080","journal-title":"Autophagy"},{"key":"1767_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"10","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 10:207:18\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033","journal-title":"J Control Release"},{"issue":"1","key":"1767_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.27874","volume":"35","author":"ME Haque","year":"2020","unstructured":"Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK (2020) Targeting the microglial NLRP3 inflammasome and its role in Parkinson\u2019s disease. Mov Disord 35(1):20\u201333. https:\/\/doi.org\/10.1002\/mds.27874","journal-title":"Mov Disord"},{"issue":"7","key":"1767_CR52","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522\u2013531. https:\/\/doi.org\/10.1038\/nrg1379","journal-title":"Nat Rev Genet"},{"issue":"1","key":"1767_CR53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12967-023-04638-x","volume":"24","author":"S He","year":"2023","unstructured":"He S, Wang Q, Chen L, He YJ, Wang X, Qu S (2023) miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson\u2019s disease model via regulation of Nox4\/ROS\/Nrf2 signaling. J Transl Med 24(1):747. https:\/\/doi.org\/10.1186\/s12967-023-04638-x","journal-title":"J Transl Med"},{"issue":"5842","key":"1767_CR54","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1126\/science.1148530","volume":"31","author":"SS Hebert","year":"2007","unstructured":"Hebert SS, De Strooper B (2007) Molecular biology. miRNAs in neurodegeneration. Science 31(5842):1179\u20131180. https:\/\/doi.org\/10.1126\/science.1148530","journal-title":"Science"},{"issue":"1","key":"1767_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"11","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener 11(1):83. https:\/\/doi.org\/10.1186\/s13024-023-00676-7","journal-title":"Mol Neurodegener"},{"issue":"23","key":"1767_CR56","doi-asserted-by":"publisher","first-page":"13693","DOI":"10.1021\/acs.chemrev.3c00479","volume":"13","author":"DR Hill","year":"2023","unstructured":"Hill DR, Huters AD, Towne TB et al (2023) Parkinson\u2019s Disease: Advances in Treatment and the Syntheses of Various Classes of Pharmaceutical Drug Substances. Chem Rev 13(23):13693\u201313712. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00479","journal-title":"Chem Rev"},{"issue":"3","key":"1767_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer C, Katz N, Buza EL et al (2018) Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hum Gene Ther 29(3):285\u2013298. https:\/\/doi.org\/10.1089\/hum.2018.015","journal-title":"Hum Gene Ther"},{"key":"1767_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","volume":"5","author":"Q Hu","year":"2016","unstructured":"Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. Transl Neurodegener 5:14. https:\/\/doi.org\/10.1186\/s40035-016-0060-6","journal-title":"Transl Neurodegener"},{"key":"1767_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577543","volume":"354","author":"S Huang","year":"2021","unstructured":"Huang S, Chen Z, Fan B et al (2021) A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease. J Neuroimmunol 354:577543. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577543","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1767_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4103\/1673-5374.380878","volume":"19","author":"S Huenchuguala","year":"2024","unstructured":"Huenchuguala S, Segura-Aguilar J (2024) Single-neuron neurodegeneration as a degenerative model for Parkinson\u2019s disease. Neural Regen Res 19(3):529\u2013535. https:\/\/doi.org\/10.4103\/1673-5374.380878","journal-title":"Neural Regen Res"},{"issue":"12","key":"1767_CR61","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"4","author":"M Izco","year":"2019","unstructured":"Izco M, Blesa J, Schleef M et al (2019) Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology. Mol Ther 4(12):2111\u20132122. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.010","journal-title":"Mol Ther"},{"issue":"2","key":"1767_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/1073858421990001","volume":"28","author":"M Izco","year":"2022","unstructured":"Izco M, Carlos E, Alvarez-Erviti L (2022) The Two Faces of Exosomes in Parkinson\u2019s Disease: From Pathology to Therapy. Neuroscientist 28(2):180\u2013193. https:\/\/doi.org\/10.1177\/1073858421990001","journal-title":"Neuroscientist"},{"issue":"6","key":"1767_CR63","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, Bartz SR, Schelter J et al (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21(6):635\u2013637. https:\/\/doi.org\/10.1038\/nbt831","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1767_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd3010","volume":"9","author":"AL Jackson","year":"2010","unstructured":"Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9(1):57\u201367. https:\/\/doi.org\/10.1038\/nrd3010","journal-title":"Nat Rev Drug Discov"},{"issue":"4 Suppl 1","key":"1767_CR65","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1212\/wnl.58.suppl_1.s19","volume":"58","author":"J Jankovic","year":"2002","unstructured":"Jankovic J (2002) Levodopa strengths and weaknesses. Neurology 58(4 Suppl 1):S19-32. https:\/\/doi.org\/10.1212\/wnl.58.suppl_1.s19","journal-title":"Neurology"},{"issue":"8","key":"1767_CR66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1767_CR67","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12264-016-0061-6","volume":"32","author":"X Jia","year":"2016","unstructured":"Jia X, Wang F, Han Y et al (2016) miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells. Neurosci Bull 32(6):512\u2013522. https:\/\/doi.org\/10.1007\/s12264-016-0061-6","journal-title":"Neurosci Bull"},{"key":"1767_CR68","doi-asserted-by":"publisher","first-page":"738530","DOI":"10.3389\/fneur.2021.738530","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Chen J, Sun Y et al (2021) Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson\u2019s Disease Patients. Front Neurol 12:738530. https:\/\/doi.org\/10.3389\/fneur.2021.738530","journal-title":"Front Neurol"},{"key":"1767_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146331","volume":"1722","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Liu J, Chen L et al (2019) Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson\u2019s disease. Brain Res 1722:146331. https:\/\/doi.org\/10.1016\/j.brainres.2019.146331","journal-title":"Brain Res"},{"issue":"10","key":"1767_CR70","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY et al (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97(10):2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Arch Toxicol"},{"key":"1767_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","volume":"19","author":"N Kayagaki","year":"2024","unstructured":"Kayagaki N, Webster JD, Newton K (2024) Control of cell death in health and disease. Annu Rev Pathol 19:157\u2013180. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051022-014433","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"1767_CR72","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41591-021-01522-3","volume":"27","author":"MS Keiser","year":"2021","unstructured":"Keiser MS, Ranum PT, Yrigollen CM et al (2021) Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain. Nat Med 27(11):1982\u20131989. https:\/\/doi.org\/10.1038\/s41591-021-01522-3","journal-title":"Nat Med"},{"issue":"3","key":"1767_CR73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43587-021-00042-6","volume":"1","author":"F Kern","year":"2021","unstructured":"Kern F, Fehlmann T, Violich I et al (2021) Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson\u2019s disease progression. Nat Aging 1(3):309\u2013322. https:\/\/doi.org\/10.1038\/s43587-021-00042-6","journal-title":"Nat Aging"},{"issue":"1","key":"1767_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0121-4","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim J, Fiesel FC, Belmonte KC et al (2016) miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol Neurodegener 11(1):55. https:\/\/doi.org\/10.1186\/s13024-016-0121-4","journal-title":"Mol Neurodegener"},{"issue":"5842","key":"1767_CR75","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"31","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J et al (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 31(5842):1220\u20131224. https:\/\/doi.org\/10.1126\/science.1140481","journal-title":"Science"},{"issue":"1","key":"1767_CR76","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"3","author":"R Kojima","year":"2018","unstructured":"Kojima R, Bojar D, Rizzi G et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 3(1):1305. https:\/\/doi.org\/10.1038\/s41467-018-03733-8","journal-title":"Nat Commun"},{"key":"1767_CR77","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2147\/IJN.S29661","volume":"7","author":"SA Kooijmans","year":"2012","unstructured":"Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM (2012) Exosome mimetics: a novel class of drug delivery systems. Int J Nanomed 7:1525\u20131541. https:\/\/doi.org\/10.2147\/IJN.S29661","journal-title":"Int J Nanomed"},{"issue":"1","key":"1767_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","volume":"18","author":"MC Kuo","year":"2021","unstructured":"Kuo MC, Liu SC, Hsu YF, Wu RM (2021) The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 18(1):78. https:\/\/doi.org\/10.1186\/s12929-021-00775-x","journal-title":"J Biomed Sci"},{"issue":"15","key":"1767_CR79","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1093\/nar\/gkz638","volume":"5","author":"X Lai","year":"2019","unstructured":"Lai X, Eberhardt M, Schmitz U, Vera J (2019) Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Res 5(15):7753\u20137766. https:\/\/doi.org\/10.1093\/nar\/gkz638","journal-title":"Nucleic Acids Res"},{"issue":"s1","key":"1767_CR80","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP Story. J Parkinsons Dis 7(s1):S11\u2013S19. https:\/\/doi.org\/10.3233\/JPD-179006","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"1767_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S et al (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26(2):213\u2013228. https:\/\/doi.org\/10.1038\/s41418-018-0124-5","journal-title":"Cell Death Differ"},{"issue":"5","key":"1767_CR82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u201354. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y","journal-title":"Cell"},{"issue":"6","key":"1767_CR83","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/med.21718","volume":"40","author":"D Li","year":"2020","unstructured":"Li D, Mastaglia FL, Fletcher S, Wilton SD (2020) Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era. Med Res Rev 40(6):2650\u20132681. https:\/\/doi.org\/10.1002\/med.21718","journal-title":"Med Res Rev"},{"issue":"2","key":"1767_CR84","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J, Luo S, Chen S, Gu Q (2018) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31(2):106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"key":"1767_CR85","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z et al (2023) PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 84:101817. https:\/\/doi.org\/10.1016\/j.arr.2022.101817","journal-title":"Ageing Res Rev"},{"key":"1767_CR86","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","volume":"5","author":"Q Li","year":"2021","unstructured":"Li Q, Wang Z, Xing H, Wang Y, Guo Y (2021) Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson\u2019s disease. Mol Ther Nucleic Acids 5:23:1334\u20131344. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1767_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00986-2","volume":"19","author":"YJ Li","year":"2021","unstructured":"Li YJ, Wu JY, Liu J et al (2021) Artificial exosomes for translational nanomedicine. J Nanobiotechnol 19(1):242. https:\/\/doi.org\/10.1186\/s12951-021-00986-2","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"1767_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s Disease: From Mechanism to Therapy. Trends Biochem Sci 46(4):329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"1767_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","volume":"20","author":"A Masato","year":"2019","unstructured":"Masato A, Plotegher N, Boassa D, Bubacco L (2019) Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis. Mol Neurodegener 20(1):35. https:\/\/doi.org\/10.1186\/s13024-019-0332-6","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1767_CR90","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"3","author":"JR Mendell","year":"2021","unstructured":"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR et al (2021) Current Clinical Applications of In Vivo Gene Therapy with AAVs. Mol Ther 3(2):464\u2013488. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.007","journal-title":"Mol Ther"},{"issue":"1","key":"1767_CR91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis 1(1):19\u201333. https:\/\/doi.org\/10.3233\/JPD-2011-11023","journal-title":"J Parkinsons Dis"},{"issue":"10423","key":"1767_CR92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"20","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 20(10423):293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"issue":"7","key":"1767_CR93","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044. https:\/\/doi.org\/10.1038\/s41418-021-00814-y","journal-title":"Cell Death Differ"},{"issue":"2","key":"1767_CR94","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM (2012) MicroRNAs in Parkinson\u2019s disease. Neurobiol Dis 46(2):279\u201384. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.046","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1767_CR95","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","volume":"21","author":"H Nakatogawa","year":"2020","unstructured":"Nakatogawa H (2020) Mechanisms governing autophagosome biogenesis. Nat Rev Mol Cell Biol 21(8):439\u2013458. https:\/\/doi.org\/10.1038\/s41580-020-0241-0","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1767_CR96","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tcb.2018.12.007","volume":"29","author":"F Napoletano","year":"2019","unstructured":"Napoletano F, Baron O, Vandenabeele P, Mollereau B, Fanto M (2019) Intersections between regulated cell death and autophagy. Trends Cell Biol 29(4):323\u2013338. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.007","journal-title":"Trends Cell Biol"},{"issue":"2","key":"1767_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2009.04.044","volume":"4","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Wilfred BR (2009) In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain. Neurosci Lett 4(2):69\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2009.04.044","journal-title":"Neurosci Lett"},{"issue":"6","key":"1767_CR98","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.29416","volume":"38","author":"J Ng","year":"2023","unstructured":"Ng J, Barral S, Waddington SN, Kurian MA (2023) Gene Therapy for Dopamine Dyshomeostasis: From Parkinson\u2019s to Primary Neurotransmitter Diseases. Mov Disord 38(6):924\u2013936. https:\/\/doi.org\/10.1002\/mds.29416","journal-title":"Mov Disord"},{"key":"1767_CR99","doi-asserted-by":"publisher","first-page":"660379","DOI":"10.3389\/fnins.2021.660379","volume":"15","author":"YH Nies","year":"2021","unstructured":"Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL (2021) MicroRNA Dysregulation in Parkinson\u2019s Disease: A Narrative Review. Front Neurosci 15:660379. https:\/\/doi.org\/10.3389\/fnins.2021.660379","journal-title":"Front Neurosci"},{"key":"1767_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1767_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110651","volume":"39","author":"K O'Brien","year":"2022","unstructured":"O\u2019Brien K, Ughetto S, Mahjoum S, Nair AV, Breakefield XO (2022) Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep 39(2):110651. https:\/\/doi.org\/10.1016\/j.celrep.2022.110651","journal-title":"Cell Rep"},{"issue":"4","key":"1767_CR102","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Taylor KI, Anzures Cabrera J et al (2024) Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat Med 30(4):1096\u20131103. https:\/\/doi.org\/10.1038\/s41591-024-02886-y","journal-title":"Nat Med"},{"issue":"1\u20132","key":"1767_CR103","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2017.12.024","volume":"172","author":"ED Pastuzyn","year":"2018","unstructured":"Pastuzyn ED, Day CE, Kearns RB et al (2018) The neuronal gene Arc encodes a repurposed retrotransposon Gag protein that mediates intercellular RNA transfer. Cell 172(1\u20132):275-288 e18. https:\/\/doi.org\/10.1016\/j.cell.2017.12.024","journal-title":"Cell"},{"issue":"5","key":"1767_CR104","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.26467","volume":"92","author":"MT Perinan","year":"2022","unstructured":"Perinan MT, Brolin K, Bandres-Ciga S et al (2022) Effect Modification between Genes and Environment and Parkinson\u2019s Disease Risk. Ann Neurol 92(5):715\u2013724. https:\/\/doi.org\/10.1002\/ana.26467","journal-title":"Ann Neurol"},{"key":"1767_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084187","author":"GP Pfeifer","year":"2024","unstructured":"Pfeifer GP (2024) DNA damage and Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25084187","journal-title":"Int J Mol Sci"},{"key":"1767_CR106","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.addr.2021.04.012","volume":"173","author":"S Rankin-Turner","year":"2021","unstructured":"Rankin-Turner S, Vader P, O\u2019Driscoll L, Giebel B, Heaney LM, Davies OG (2021) A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos. Adv Drug Deliv Rev 173:479\u2013491. https:\/\/doi.org\/10.1016\/j.addr.2021.04.012","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"1767_CR107","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/acn3.51146","volume":"7","author":"S Ravanidis","year":"2020","unstructured":"Ravanidis S, Bougea A, Papagiannakis N et al (2020) Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients. Ann Clin Transl Neurol 7(9):1594\u20131607. https:\/\/doi.org\/10.1002\/acn3.51146","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1767_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0958-1669(03)00068-5","volume":"14","author":"MC Roco","year":"2003","unstructured":"Roco MC (2003) Nanotechnology: convergence with modern biology and medicine. Curr Opin Biotechnol 14(3):337\u2013346. https:\/\/doi.org\/10.1016\/s0958-1669(03)00068-5","journal-title":"Curr Opin Biotechnol"},{"key":"1767_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04111-w","author":"MJ Saadh","year":"2024","unstructured":"Saadh MJ, Faisal A, Adil M et al (2024) Parkinson\u2019s disease and microRNAs: a duel between inhibition and stimulation of apoptosis in neuronal cells. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04111-w","journal-title":"Mol Neurobiol"},{"issue":"8","key":"1767_CR110","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.molmed.2019.05.006","volume":"25","author":"A Sadlon","year":"2019","unstructured":"Sadlon A, Takousis P, Alexopoulos P, Evangelou E, Prokopenko I, Perneczky R (2019) MiRNAs identify shared pathways in Alzheimer\u2019s and Parkinson\u2019s diseases. Trends Mol Med 25(8):662\u2013672. https:\/\/doi.org\/10.1016\/j.molmed.2019.05.006","journal-title":"Trends Mol Med"},{"key":"1767_CR111","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bcp.2017.07.008","volume":"141","author":"C Saraiva","year":"2017","unstructured":"Saraiva C, Esteves M, Bernardino L (2017) MicroRNA: basic concepts and implications for regeneration and repair of neurodegenerative diseases. Biochem Pharmacol 141:118\u2013131. https:\/\/doi.org\/10.1016\/j.bcp.2017.07.008","journal-title":"Biochem Pharmacol"},{"key":"1767_CR112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235:34\u201347. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.044","journal-title":"J Control Release"},{"issue":"3","key":"1767_CR113","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1152\/physrev.00006.2010","volume":"91","author":"D Sayed","year":"2011","unstructured":"Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91(3):827\u2013887. https:\/\/doi.org\/10.1152\/physrev.00006.2010","journal-title":"Physiol Rev"},{"issue":"6","key":"1767_CR114","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.tips.2017.03.010","volume":"38","author":"S Schildknecht","year":"2017","unstructured":"Schildknecht S, Di Monte DA, Pape R, Tieu K, Leist M (2017) Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP. Trends Pharmacol Sci 38(6):541\u2013555. https:\/\/doi.org\/10.1016\/j.tips.2017.03.010","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"1767_CR115","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","volume":"15","author":"M Segal","year":"2020","unstructured":"Segal M, Slack FJ (2020) Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opin Drug Discov 15(9):987\u2013992. https:\/\/doi.org\/10.1080\/17460441.2020.1765770","journal-title":"Expert Opin Drug Discov"},{"key":"1767_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071523","author":"Z Slyk","year":"2024","unstructured":"Slyk Z, Stachowiak N, Malecki M (2024) Recombinant adeno-associated virus vectors for gene therapy of the central nervous system: delivery routes and clinical aspects. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12071523","journal-title":"Biomedicines"},{"issue":"2","key":"1767_CR117","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12079-020-00552-9","volume":"14","author":"M Somiya","year":"2020","unstructured":"Somiya M (2020) Where does the cargo go?: solutions to provide experimental support for the \u201cextracellular vesicle cargo transfer hypothesis.\u201d J Cell Commun Signal 14(2):135\u2013146. https:\/\/doi.org\/10.1007\/s12079-020-00552-9","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"1767_CR118","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.27542","volume":"34","author":"C Starhof","year":"2019","unstructured":"Starhof C, Hejl AM, Heegaard NHH et al (2019) The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes. Mov Disord 34(2):246\u2013254. https:\/\/doi.org\/10.1002\/mds.27542","journal-title":"Mov Disord"},{"key":"1767_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2022.02.007","volume":"14","author":"CS Stein","year":"2022","unstructured":"Stein CS, McLendon JM, Witmer NH, Boudreau RL (2022) Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson\u2019s disease. Mol Ther Nucleic Acids 14:1\u201315. https:\/\/doi.org\/10.1016\/j.omtn.2022.02.007","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"1767_CR120","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y, Deng MF, Xiong W et al (2019) MicroRNA-26a\/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson\u2019s Disease. Biol Psychiatry 85(9):769\u2013781. https:\/\/doi.org\/10.1016\/j.biopsych.2018.12.008","journal-title":"Biol Psychiatry"},{"issue":"12","key":"1767_CR121","doi-asserted-by":"publisher","first-page":"23379","DOI":"10.1002\/jcp.28907","volume":"234","author":"Q Sun","year":"2019","unstructured":"Sun Q, Wang S, Chen J et al (2019) MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson\u2019s disease mouse model. J Cell Physiol 234(12):23379\u201323387. https:\/\/doi.org\/10.1002\/jcp.28907","journal-title":"J Cell Physiol"},{"issue":"11","key":"1767_CR122","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1767_CR123","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Teresak","year":"2022","unstructured":"Teresak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A (2022) Regulation of PRKN-independent mitophagy. Autophagy 18(1):24\u201339. https:\/\/doi.org\/10.1080\/15548627.2021.1888244","journal-title":"Autophagy"},{"issue":"8","key":"1767_CR124","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"24","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG (2016) microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. J Neurosci 24(8):2383\u20132390. https:\/\/doi.org\/10.1523\/JNEUROSCI.3900-15.2016","journal-title":"J Neurosci"},{"issue":"s1","key":"1767_CR125","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.3233\/JAD-220449","volume":"94","author":"KP Tryphena","year":"2023","unstructured":"Tryphena KP, Anuradha U, Kumar R et al (2023) Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson\u2019s Disease. J Alzheimers Dis 94(s1):S187\u2013S202. https:\/\/doi.org\/10.3233\/JAD-220449","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1767_CR126","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jconrel.2011.11.021","volume":"20","author":"SM van Dommelen","year":"2012","unstructured":"van Dommelen SM, Vader P, Lakhal S et al (2012) Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 20(2):635\u2013644. https:\/\/doi.org\/10.1016\/j.jconrel.2011.11.021","journal-title":"J Control Release"},{"issue":"3","key":"1767_CR127","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","volume":"24","author":"JNS Vargas","year":"2023","unstructured":"Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T (2023) The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol 24(3):167\u2013185. https:\/\/doi.org\/10.1038\/s41580-022-00542-2","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1767_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113972","volume":"243","author":"B Vellingiri","year":"2022","unstructured":"Vellingiri B, Chandrasekhar M, Sri Sabari S et al (2022) Neurotoxicity of pesticides - A link to neurodegeneration. Ecotoxicol Environ Saf 243:113972. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113972","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"1767_CR129","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E et al (2023) Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ 30(5):1097\u20131154. https:\/\/doi.org\/10.1038\/s41418-023-01153-w","journal-title":"Cell Death Differ"},{"issue":"6","key":"1767_CR130","doi-asserted-by":"publisher","first-page":"e10248","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. Embo Mol Med 11(6):e10248. https:\/\/doi.org\/10.15252\/emmm.201810248","journal-title":"Embo Mol Med"},{"issue":"1","key":"1767_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"issue":"4","key":"1767_CR132","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"11","author":"X Wang","year":"2011","unstructured":"Wang X, Winter D, Ashrafi G et al (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 11(4):893\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2011.10.018","journal-title":"Cell"},{"key":"1767_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042009","author":"H Watanabe","year":"2024","unstructured":"Watanabe H, Dijkstra JM, Nagatsu T (2024) Parkinson\u2019s disease: cells succumbing to lifelong dopamine-related oxidative stress and other bioenergetic challenges. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25042009","journal-title":"Int J Mol Sci"},{"key":"1767_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.631553","volume":"14","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li Y, Yang H, Guo J, Li N (2021) Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson\u2019s Disease. Front Mol Neurosci 14:631553. https:\/\/doi.org\/10.3389\/fnmol.2021.631553","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1767_CR135","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","volume":"12","author":"L Yao","year":"2018","unstructured":"Yao L, Ye Y, Mao H et al (2018) MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. J Neuroinflammation 12(1):13. https:\/\/doi.org\/10.1186\/s12974-018-1053-4","journal-title":"J Neuroinflammation"},{"issue":"7","key":"1767_CR136","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"L Yao","year":"2019","unstructured":"Yao L, Zhu Z, Wu J et al (2019) MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 33(7):8648\u20138665. https:\/\/doi.org\/10.1096\/fj.201900363R","journal-title":"FASEB J"},{"issue":"5","key":"1767_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104709","volume":"299","author":"M Yoo","year":"2023","unstructured":"Yoo M, Choi DC, Murphy A, Ahsan AM, Junn E (2023) MicroRNA-593-5p contributes to cell death following exposure to 1-methyl-4-phenylpyridinium by targeting PTEN-induced putative kinase 1. J Biol Chem 299(5):104709. https:\/\/doi.org\/10.1016\/j.jbc.2023.104709","journal-title":"J Biol Chem"},{"issue":"5","key":"1767_CR138","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D (2024) A guide to cell death pathways. Nat Rev Mol Cell Biol 25(5):379\u2013395. https:\/\/doi.org\/10.1038\/s41580-023-00689-6","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1767_CR139","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/med.21962","volume":"43","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang J, Wang Y et al (2023) Targeting epigenetic modifications in Parkinson\u2019s disease therapy. Med Res Rev 43(5):1748\u20131777. https:\/\/doi.org\/10.1002\/med.21962","journal-title":"Med Res Rev"},{"issue":"4","key":"1767_CR140","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s13311-021-01130-6","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhao M, Yan R et al (2021) MicroRNA-7 Protects Against Neurodegeneration Induced by alpha-Synuclein Preformed Fibrils in the Mouse Brain. Neurotherapeutics 18(4):2529\u20132540. https:\/\/doi.org\/10.1007\/s13311-021-01130-6","journal-title":"Neurotherapeutics"},{"key":"1767_CR141","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S288859","volume":"15","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cheng Z, Wang Y, Han T (2021) The Risks of miRNA Therapeutics: In a Drug Target Perspective. Drug Des Devel Ther 15:721\u2013733. https:\/\/doi.org\/10.2147\/DDDT.S288859","journal-title":"Drug Des Devel Ther"},{"key":"1767_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111822","volume":"185","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xu A, Lv J et al (2020) Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. Eur J Med Chem 185:111822. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111822","journal-title":"Eur J Med Chem"},{"key":"1767_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105197","volume":"160","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhao Y, Li Z et al (2020) miR-103a-3p regulates mitophagy in Parkinson\u2019s disease through Parkin\/Ambra1 signaling. Pharmacol Res 160:105197. https:\/\/doi.org\/10.1016\/j.phrs.2020.105197","journal-title":"Pharmacol Res"},{"issue":"1","key":"1767_CR144","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du RH et al (2016) MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 11(1):28. https:\/\/doi.org\/10.1186\/s13024-016-0094-3","journal-title":"Mol Neurodegener"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01767-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:55:54Z","timestamp":1789433754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01767-x","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"140"}}